The NMN sector of the dietary supplement industry has experienced significant damage from rogue regulators continuing their assault against products this industry provides consumers. We have engaged Congress on the issue and have submitted a citizen’s petition requesting the agency:
- Determine nicotinamide mononucleotide (NMN) is not excluded from the definition of a dietary supplement under 21 U.S.C. §321(ff)(3)(B);
- Commit to exercising enforcement discretion in connection with the marketing and selling of NMN in or as a dietary supplement; or
- In the alternative, recommend the Secretary of Health and Human Services (HHS) issue a regulation after notice comment, finding NMN would be lawful.
Click here to read NPA’s citizen petition.
Protect Access to NMN Dietary Supplements
We are calling on all health and wellness advocates to protect NMN supplements by writing to their members of congress, demanding they hold FDA accountable. The issues surrounding NAC and NMN are glaring examples of the FDA fundamentally failing American consumers and industry. Our Citizen’s Petition on NMN positions NPA to have all available options needed to rectify NMN’s unwarranted regulatory uncertainty. However, we still need your help, so please write to your members of congress today.
Click here to take action now!
NMN Letters:
Congressman Jeff Duncan Letter to FDA
NMN News:
NPA, ANH File Citizen’s Petition with FDA on NMN
Petition To US FDA For Using NMN In Supplements Reminds Agency Of Its Reversal On NAC
Idaho Legislature Protects Dietary Supplements Like NMN in New Bill
Health organisations petition FDA to reverse its position on NMN supplements
NPA and ANH file Citizen’s Petition requesting FDA reevaluate its position on NMN
ANH, NPA ask FDA to reverse position on NMN supplements
Off the shelves: Amazon bans NMN products
For more information, please contact us at kturk@NPAnational.org.
